When you’re diagnosed with prostate cancer, one of the first questions you may have is: “What does this mean for my life expectancy?” Prostate cancer can behave in different ways, and prognosis is dependent on the person, the stage of the cancer, and many other factors.
The good news is that many people with prostate cancer live long lives, especially when the cancer is found early. Overall survival rates are high for prostate cancer that hasn’t spread to other parts of the body, and treatments keep improving. Still, everyone’s situation is unique. Your oncologist (cancer doctor) is the best person to help you understand your own outlook.
Below is a list of key factors that can affect prostate cancer survival and long-term health.
Among all cancers, prostate cancer has one of the highest survival rates. When found early, before it spreads beyond the prostate, the five-year survival rate is nearly 100 percent. That means that people with localized prostate cancer often live just as long as people without prostate cancer.
Even when prostate cancer has spread to nearby tissues or lymph nodes, survival rates are still very high. More advanced cancer that spreads to distant areas — like the bones, lungs, or liver — does lower the five-year survival rate to around 38 percent, but treatments continue to improve.
Remember, survival rates and cancer statistics are estimates based on trends in the overall population, but individuals within the population have different characteristics. They give a general sense of what may happen to you as an individual if you have the same characteristics as the population, but they cannot exactly predict your survival.
A cancer’s stage describes how large the tumor is and how far the cancer has spread in your body. This is one of the most important factors in the long-term outlook of prostate cancer.
Localized prostate cancer means that the cancer is only in the prostate. This type grows slowly, and many people live with it for decades.
Regional prostate cancer has spread just outside the prostate and to nearby lymph nodes, but not to distant organs. It’s still highly treatable, and five-year survival rates remain close to 100 percent.
Metastatic prostate cancer has spread to distant parts of the body, often to the bones, but can also reach the brain, liver, and lungs. Treatments can control advanced prostate cancer for years, but they do affect life expectancy more than earlier stages.
Knowing your stage helps you and your healthcare team decide what treatment plan works best for your long-term goals and overall quality of life.
Besides being one of the biggest risk factors for developing prostate cancer, age also impacts life expectancy. Most people are diagnosed after age 65. As you get older, your body goes through changes that make cancer more likely to develop.
Older adults also tend to have more health problems, which can affect treatment choices and recovery. Still, many older individuals with slow-growing prostate cancer do very well and may not need treatment right away.
Younger people diagnosed with prostate cancer may have faster-growing cancer or genetic risk factors, which can change the outlook. Your doctor will talk through how age affects your treatment options.
On a population level, prostate cancer affects racial and ethnic groups differently. According to the American Cancer Society, in the United States, Black men:
Certain racial and ethnic groups in the United States, including American Indian/Alaska Native, Asian American/Pacific Islander, and Hispanic populations, are less likely than Black and white populations to be diagnosed with localized disease, according to the American Cancer Society. This means individuals in these populations are likely to get diagnosed later.
These differences aren’t due to biology alone. Social factors like access to care, insurance coverage, neighborhood resources, and long-term stress also play a major role.
Other groups, like people living with limited access to screening or those living in rural areas, may face delays in diagnosis or treatment. Early screening discussions and regular medical care can help improve long-term outcomes.
Having other chronic health conditions (comorbidities) in addition to prostate cancer can impact your overall outlook. Common conditions that can affect survival in prostate cancer include:
If you have multiple health problems, certain treatments may not be recommended. Your doctor will balance treatment benefits with your overall health to create a plan you can tolerate and maintain over time.
Some people — up to 10 percent of people with prostate cancer — carry inherited genetic changes that increase their risk or make the cancer more aggressive. These include mutations in:
Having these mutations doesn’t guarantee a shorter life expectancy, but it may change how your prostate cancer is treated. Genetic testing may help you understand your risk and guide your treatment, especially if you have a strong family history of prostate or other cancers.
The cancer’s grade, also called the Gleason score for prostate cancer, describes how abnormal the cancer cells look under a microscope. Risk can be split into high, medium, or low, depending on the Gleason grade group. Low-grade cancer cells (with a score of 6 or less) look close to normal and tend to grow slowly. High-grade cancer cells (with a score between 8 and 10) look more abnormal and are more likely to spread. You can usually find the Gleason score in your biopsy report (pathology report).
Low-grade cancers often stay in the prostate for years and may not have a large impact on life expectancy. High-risk prostate cancer may need more aggressive treatment and closer monitoring.
This score helps your doctors understand how the cancer might behave in the long term.
Treatment of prostate cancer isn’t one-size-fits-all. Treatment options include one or many of the following:
If you’ve recently been diagnosed, you and your doctor can discuss the best initial treatment for you through shared decision-making. You should discuss the length and cost of treatment, possible side effects, and potential complications.
Some people respond very well to treatment, staying in remission for years. Others may have cancer that returns or becomes difficult to treat. Your long-term outlook depends on how your cancer behaves and how well treatments work for you.
If first-line treatments stop working and prostate cancer has spread or come back, other treatments may still help slow the cancer and improve your quality of life. Joining a clinical trial is also an option.
Studies suggest that certain habits may support better long-term outcomes for people with prostate cancer. While lifestyle choices won’t cure cancer, they can keep your body stronger and support treatment. Try out as many of these healthy habits as you can to promote wellness:
Talk to your doctor before making any major lifestyle changes, especially during treatment.
Regular medical visits play a key role in your overall health and survival. Keeping up with your care team before, during, and after prostate cancer treatment allows them to look for new symptoms, track your disease course, and adjust treatments as needed. Speaking openly with your doctor can help you improve your outcomes and overall quality of life.
On MyProstateCancerTeam, people share their experiences with prostate cancer, get advice, and find support from others who understand.
Have you spoken to your doctor about your prostate cancer prognosis? Let others know in a comment below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
A MyProstateCancerTeam Member
Very informative.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.